Long-term results of first salvage treatment in CLL patients treated initially with FCR (fludarabine, cyclophosphamide, rituximab)

Although fludarabine, cyclophosphamide, and rituximab (FCR) together are established as a standard first-line treatment of younger patients with chronic lymphocytic leukemia (CLL), there is little information to guide the management of patients with CLL refractory to, or who have relapsed after, rec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Tam, Constantine S., O’Brien, Susan, Plunkett, William, Wierda, William, Ferrajoli, Alessandra, Wang, Xuemei, Do, Kim-Anh, Cortes, Jorge, Khouri, Issa, Kantarjian, Hagop, Lerner, Susan, Keating, Michael J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2014
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4231417/
https://ncbi.nlm.nih.gov/pubmed/25281606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-06-583765
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados